Global Hepatitis A Vaccine Market Insights, Forecast to 2025

Publisher Name :
Date: 30-Apr-2019
No. of pages: 111
Inquire Before Buying

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

Two types of HAV vaccines are currently available internationally:

1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.

Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

The global Hepatitis A Vaccine market is valued at 650 million US$ in 2018 and will reach 760 million US$ by the end of 2025, growing at a CAGR of 2.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hepatitis A Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Hepatitis A Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hepatitis A Vaccine in these regions.

This research report categorizes the global Hepatitis A Vaccine market by top players/brands, region, type and end user. This report also studies the global Hepatitis A Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- GSK

- Merck

- Sanofi

- Sinovac

- Zhejiang Pukang

- Changchun Institute of Biological

- Kaketsuken

- IMBCA

- ChangSheng

- Convac

Market size by Product

- Inactivated Vaccine

- Live Attenuated Vaccine

Market size by End User

- Government Institution

- Private Sector

- Other

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Hepatitis A Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Hepatitis A Vaccine market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Hepatitis A Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Hepatitis A Vaccine submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Hepatitis A Vaccine are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hepatitis A Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Hepatitis A Vaccine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Hepatitis A Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Hepatitis A Vaccine Market Size Growth Rate by Product
1.4.2 Inactivated Vaccine
1.4.3 Live Attenuated Vaccine
1.5 Market by End User
1.5.1 Global Hepatitis A Vaccine Market Size Growth Rate by End User
1.5.2 Government Institution
1.5.3 Private Sector
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hepatitis A Vaccine Market Size
2.1.1 Global Hepatitis A Vaccine Revenue 2014-2025
2.1.2 Global Hepatitis A Vaccine Sales 2014-2025
2.2 Hepatitis A Vaccine Growth Rate by Regions
2.2.1 Global Hepatitis A Vaccine Sales by Regions
2.2.2 Global Hepatitis A Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Hepatitis A Vaccine Sales by Manufacturers
3.1.1 Hepatitis A Vaccine Sales by Manufacturers
3.1.2 Hepatitis A Vaccine Sales Market Share by Manufacturers
3.1.3 Global Hepatitis A Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Hepatitis A Vaccine Revenue by Manufacturers
3.2.1 Hepatitis A Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Hepatitis A Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 Hepatitis A Vaccine Price by Manufacturers
3.4 Hepatitis A Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Hepatitis A Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hepatitis A Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Hepatitis A Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Hepatitis A Vaccine Sales by Product
4.2 Global Hepatitis A Vaccine Revenue by Product
4.3 Hepatitis A Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Hepatitis A Vaccine Breakdown Data by End User
6 North America
6.1 North America Hepatitis A Vaccine by Countries
6.1.1 North America Hepatitis A Vaccine Sales by Countries
6.1.2 North America Hepatitis A Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Hepatitis A Vaccine by Product
6.3 North America Hepatitis A Vaccine by End User
7 Europe
7.1 Europe Hepatitis A Vaccine by Countries
7.1.1 Europe Hepatitis A Vaccine Sales by Countries
7.1.2 Europe Hepatitis A Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hepatitis A Vaccine by Product
7.3 Europe Hepatitis A Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Hepatitis A Vaccine by Countries
8.1.1 Asia Pacific Hepatitis A Vaccine Sales by Countries
8.1.2 Asia Pacific Hepatitis A Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Hepatitis A Vaccine by Product
8.3 Asia Pacific Hepatitis A Vaccine by End User
9 Central & South America
9.1 Central & South America Hepatitis A Vaccine by Countries
9.1.1 Central & South America Hepatitis A Vaccine Sales by Countries
9.1.2 Central & South America Hepatitis A Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Hepatitis A Vaccine by Product
9.3 Central & South America Hepatitis A Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Hepatitis A Vaccine by Countries
10.1.1 Middle East and Africa Hepatitis A Vaccine Sales by Countries
10.1.2 Middle East and Africa Hepatitis A Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Hepatitis A Vaccine by Product
10.3 Middle East and Africa Hepatitis A Vaccine by End User
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 Company Business Overview
11.1.3 GSK Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 GSK Hepatitis A Vaccine Products Offered
11.1.5 GSK Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Business Overview
11.2.3 Merck Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Merck Hepatitis A Vaccine Products Offered
11.2.5 Merck Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Business Overview
11.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Sanofi Hepatitis A Vaccine Products Offered
11.3.5 Sanofi Recent Development
11.4 Sinovac
11.4.1 Sinovac Company Details
11.4.2 Company Business Overview
11.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sinovac Hepatitis A Vaccine Products Offered
11.4.5 Sinovac Recent Development
11.5 Zhejiang Pukang
11.5.1 Zhejiang Pukang Company Details
11.5.2 Company Business Overview
11.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Zhejiang Pukang Hepatitis A Vaccine Products Offered
11.5.5 Zhejiang Pukang Recent Development
11.6 Changchun Institute of Biological
11.6.1 Changchun Institute of Biological Company Details
11.6.2 Company Business Overview
11.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Changchun Institute of Biological Hepatitis A Vaccine Products Offered
11.6.5 Changchun Institute of Biological Recent Development
11.7 Kaketsuken
11.7.1 Kaketsuken Company Details
11.7.2 Company Business Overview
11.7.3 Kaketsuken Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Kaketsuken Hepatitis A Vaccine Products Offered
11.7.5 Kaketsuken Recent Development
11.8 IMBCA
11.8.1 IMBCA Company Details
11.8.2 Company Business Overview
11.8.3 IMBCA Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 IMBCA Hepatitis A Vaccine Products Offered
11.8.5 IMBCA Recent Development
11.9 ChangSheng
11.9.1 ChangSheng Company Details
11.9.2 Company Business Overview
11.9.3 ChangSheng Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 ChangSheng Hepatitis A Vaccine Products Offered
11.9.5 ChangSheng Recent Development
11.10 Convac
11.10.1 Convac Company Details
11.10.2 Company Business Overview
11.10.3 Convac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Convac Hepatitis A Vaccine Products Offered
11.10.5 Convac Recent Development
12 Future Forecast
12.1 Hepatitis A Vaccine Market Forecast by Regions
12.1.1 Global Hepatitis A Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global Hepatitis A Vaccine Revenue Forecast by Regions 2019-2025
12.2 Hepatitis A Vaccine Market Forecast by Product
12.2.1 Global Hepatitis A Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global Hepatitis A Vaccine Revenue Forecast by Product 2019-2025
12.3 Hepatitis A Vaccine Market Forecast by End User
12.4 North America Hepatitis A Vaccine Forecast
12.5 Europe Hepatitis A Vaccine Forecast
12.6 Asia Pacific Hepatitis A Vaccine Forecast
12.7 Central & South America Hepatitis A Vaccine Forecast
12.8 Middle East and Africa Hepatitis A Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hepatitis A Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Hepatitis A Vaccine Product Picture
Table Hepatitis A Vaccine Market Segments
Table Key Manufacturers Hepatitis A Vaccine Covered
Table Global Hepatitis A Vaccine Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Hepatitis A Vaccine Sales Market Share by Product 2014-2025
Figure Inactivated Vaccine Product Picture
Table Major Manufacturers of Inactivated Vaccine
Figure Live Attenuated Vaccine Product Picture
Table Major Manufacturers of Live Attenuated Vaccine
Table Global Hepatitis A Vaccine Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Government Institution
Figure Private Sector
Figure Other
Figure Hepatitis A Vaccine Report Years Considered
Figure Global Hepatitis A Vaccine Market Size 2014-2025 (Million US$)
Figure Global Hepatitis A Vaccine Sales 2014-2025 (K Units)
Table Global Hepatitis A Vaccine Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Hepatitis A Vaccine Sales by Regions 2014-2019 (K Units)
Table Global Hepatitis A Vaccine Sales Market Share by Regions 2014-2019
Figure Global Hepatitis A Vaccine Sales Market Share by Regions 2014-2019
Figure 2018 Global Hepatitis A Vaccine Sales Market Share by Regions
Table Global Hepatitis A Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Hepatitis A Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Hepatitis A Vaccine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Hepatitis A Vaccine Revenue Market Share by Regions
Table Global Hepatitis A Vaccine Sales by Manufacturers (2014-2019) (K Units)
Table Global Hepatitis A Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Hepatitis A Vaccine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Hepatitis A Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Hepatitis A Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Hepatitis A Vaccine Value Share by Manufacturers in 2018
Table Key Manufacturers Hepatitis A Vaccine Price (2014-2019) (USD/Unit)
Table Hepatitis A Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Hepatitis A Vaccine Product Type
Table Date of International Manufacturers Enter into Hepatitis A Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Hepatitis A Vaccine Sales by Product (2014-2019) (K Units)
Table Global Hepatitis A Vaccine Sales Share by Product (2014-2019)
Figure Global Hepatitis A Vaccine Sales Market Share by Product (2014-2019)
Figure Global Hepatitis A Vaccine Sales Market Share by Product in 2018
Table Global Hepatitis A Vaccine Revenue by Product (2014-2019) (Million US$)
Table Global Hepatitis A Vaccine Revenue Share by Product (2014-2019)
Figure Global Hepatitis A Vaccine Revenue Market Share by Product (2014-2019)
Figure Global Hepatitis A Vaccine Revenue Market Share by Product in 2018
Table Hepatitis A Vaccine Price by Product 2014-2019 (USD/Unit)
Table Global Hepatitis A Vaccine Sales by End User (2014-2019) (K Units)
Table Global Hepatitis A Vaccine Sales Share by End User (2014-2019)
Figure Global Sales Hepatitis A Vaccine Market Share by End User (2014-2019)
Figure Global Sales Hepatitis A Vaccine Market Share by End User in 2018
Figure North America Hepatitis A Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure North America Hepatitis A Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Hepatitis A Vaccine Sales by Countries (2014-2019) (K Units)
Table North America Hepatitis A Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Hepatitis A Vaccine Sales Market Share by Countries
Table North America Hepatitis A Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Hepatitis A Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Hepatitis A Vaccine Revenue Market Share by Countries
Figure United States Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure United States Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Canada Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Hepatitis A Vaccine Sales by Product (2014-2019) (K Units)
Table North America Hepatitis A Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 North America Hepatitis A Vaccine Market Share by Product
Table North America Hepatitis A Vaccine Sales by End User (2014-2019) (K Units)
Table North America Hepatitis A Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 North America Hepatitis A Vaccine Market Share by End User
Figure Europe Hepatitis A Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Europe Hepatitis A Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Hepatitis A Vaccine Sales by Countries (2014-2019) (K Units)
Table Europe Hepatitis A Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Hepatitis A Vaccine Sales Market Share by Countries
Table Europe Hepatitis A Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Hepatitis A Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Hepatitis A Vaccine Revenue Market Share by Countries
Figure Germany Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Germany Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure France Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure UK Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Italy Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Russia Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Hepatitis A Vaccine Sales by Product (2014-2019) (K Units)
Table Europe Hepatitis A Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Hepatitis A Vaccine Market Share by Product
Table Europe Hepatitis A Vaccine Sales by End User (2014-2019) (K Units)
Table Europe Hepatitis A Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Hepatitis A Vaccine Market Share by End User
Figure Asia Pacific Hepatitis A Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Hepatitis A Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Hepatitis A Vaccine Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Hepatitis A Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Hepatitis A Vaccine Sales Market Share by Countries
Table Asia Pacific Hepatitis A Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Hepatitis A Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Hepatitis A Vaccine Revenue Market Share by Countries
Figure China Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure China Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Japan Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Korea Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure India Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Australia Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Hepatitis A Vaccine Sales by Product (2014-2019) (K Units)
Table Asia Pacific Hepatitis A Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Hepatitis A Vaccine Market Share by Product
Table Asia Pacific Hepatitis A Vaccine Sales by End User (2014-2019) (K Units)
Table Asia Pacific Hepatitis A Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Hepatitis A Vaccine Market Share by End User
Figure Central & South America Hepatitis A Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Hepatitis A Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Hepatitis A Vaccine Sales by Countries (2014-2019) (K Units)
Table Central & South America Hepatitis A Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Hepatitis A Vaccine Sales Market Share by Countries
Table Central & South America Hepatitis A Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Hepatitis A Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Hepatitis A Vaccine Revenue Market Share by Countries
Figure Brazil Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Hepatitis A Vaccine Sales by Product (2014-2019) (K Units)
Table Central & South America Hepatitis A Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Hepatitis A Vaccine Market Share by Product
Table Central & South America Hepatitis A Vaccine Sales by End User (2014-2019) (K Units)
Table Central & South America Hepatitis A Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Hepatitis A Vaccine Market Share by End User
Figure Middle East and Africa Hepatitis A Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Hepatitis A Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Hepatitis A Vaccine Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Hepatitis A Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Hepatitis A Vaccine Sales Market Share by Countries
Table Middle East and Africa Hepatitis A Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Countries
Figure GCC Countries Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Hepatitis A Vaccine Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Hepatitis A Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Hepatitis A Vaccine Market Share by Product
Table Middle East and Africa Hepatitis A Vaccine Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Hepatitis A Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Hepatitis A Vaccine Market Share by End User
Table GSK Company Details
Table GSK Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Recent Development
Table Merck Company Details
Table Merck Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Sanofi Company Details
Table Sanofi Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Sinovac Company Details
Table Sinovac Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sinovac Recent Development
Table Zhejiang Pukang Company Details
Table Zhejiang Pukang Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Zhejiang Pukang Recent Development
Table Changchun Institute of Biological Company Details
Table Changchun Institute of Biological Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Changchun Institute of Biological Recent Development
Table Kaketsuken Company Details
Table Kaketsuken Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Kaketsuken Recent Development
Table IMBCA Company Details
Table IMBCA Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table IMBCA Recent Development
Table ChangSheng Company Details
Table ChangSheng Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table ChangSheng Recent Development
Table Convac Company Details
Table Convac Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Convac Recent Development
Table Global Hepatitis A Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Table Global Hepatitis A Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Hepatitis A Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Hepatitis A Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table Global Hepatitis A Vaccine Sales Forecast by Product 2019-2025 (K Units)
Table Global Hepatitis A Vaccine Sales Market Share Forecast by Product 2019-2025
Table Global Hepatitis A Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Hepatitis A Vaccine Revenue Market Share Forecast by Product 2019-2025
Table Global Hepatitis A Vaccine Sales Forecast by End User 2019-2025 (K Units)
Table Global Hepatitis A Vaccine Sales Market Share Forecast by End User 2019-2025
Figure North America Hepatitis A Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Hepatitis A Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Hepatitis A Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Hepatitis A Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Hepatitis A Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Hepatitis A Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Hepatitis A Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Hepatitis A Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Hepatitis A Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Hepatitis A Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Hepatitis A Vaccine Value Chain
Table Hepatitis A Vaccine Customers List
Table Hepatitis A Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Thymosin Beta 4 Antibody Industry Market Research Report
    Published: 17-Oct-2019        Price: US 2960 Onwards        Pages: 107
    The Thymosin Beta 4 Antibody market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Thymosin Beta 4 Antibody industrial chain, this report mainly elaborates the definition, types, applications and major players of Thymosin Beta 4 Antibody market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise p......
  • Global Hepatitis A Vaccine Market Study 2016-2026, by Segment (Liver Inactivated Vaccine, Live Attenuated Vaccine) , by Market (Hospitals, Other Medical Institutions) , by Company (GlaxoSmithKline, Merck Sharp & Dohme Corp,)
    Published: 12-Oct-2019        Price: US 1800 Onwards        Pages: 56
    Summary The global Hepatitis A Vaccine market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Liver Inactivated Vaccine - Live Attenuated Vaccine Demand Coverage (Market Size & Forecast, Consumer Distribution): - Hospitals - Other Medical Institutions Company Coverage (Sales data, Main Products &......
  • Global Hepatitis Drugs Market Professional Survey Report 2019
    Published: 08-Oct-2019        Price: US 3500 Onwards        Pages: 102
    Hepatitis is an inflammatory condition that occurs due to infection by hepatitis virus. It predominantly affects the liver and also causes damage to other body parts such as digestive system and brain. Apart from viral infections, hepatitis can also be caused by toxic substances, alcohol consumption, and autoimmune diseases. The viruses that cause hepatitis are of several types: A, B, C, D, E, and G. The most common type of hepatitis viruses are A, B, and C. Hepatitis viruses can cause either ac......
  • Global Hepatitis A Vaccine Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 23-Sep-2019        Price: US 2900 Onwards        Pages: 189
    The Hepatitis A Vaccine market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Hepatitis A Vaccine. Global Hepatitis A Vaccine industry market professional research 2014-2024, is a report which provides the details about industry overview, industry chain, market size (sal......
  • Global and China Hepatitis A Vaccine Market Research by Company, Type & Application 2013-2025
    Published: 20-Sep-2019        Price: US 2000 Onwards        Pages: 69
    Summary Market Segment as follows: By Type - Liver Inactivated Vaccine - Live Attenuated Vaccine By Application - Hospitals - Other Medical Institutions By Company - GlaxoSmithKline - Merck Sharp & Dohme Corp - SANOFI PASTEUR S.A - Norvatis - Crucell Switzerland AG(Berna+Crucell) - China Academy of Medical Sciences - Changchun Institute of Biological Products - ......
  • Autoimmune Hepatitis Pipeline Insight, 2019
    Published: 13-Sep-2019        Price: US 1250 Onwards        Pages: 60
    Autoimmune Hepatitis (Lupoid hepatitis) Overview: "Autoimmune Hepatitis (AIH) - Pipeline Insight, 2019" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Autoimmune Hepatitis pipeline landscape is provided which includes the disease overview and Autoimmune Hepatitis treatment guidelines. The assessment part of the report embraces, in depth Autoimmune Hepatitis commercial as......
  • Global Hepatitis B Vaccine Industry Market Research Report
    Published: 12-Sep-2019        Price: US 2960 Onwards        Pages: 108
    The Hepatitis B Vaccine market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Hepatitis B Vaccine industrial chain, this report mainly elaborates the definition, types, applications and major players of Hepatitis B Vaccine market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, indust......
  • Global Human Hepatitis B Immunoglobulin Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 04-Sep-2019        Price: US 2900 Onwards        Pages: 178
    The Human Hepatitis B Immunoglobulin market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Human Hepatitis B Immunoglobulin. Global Human Hepatitis B Immunoglobulin industry market professional research 2014-2024, is a report which provides the details about industry ove......
  • Global Prophylactic Hepatitis B Virus Vaccines Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 02-Sep-2019        Price: US 2900 Onwards        Pages: 184
    The Prophylactic Hepatitis B Virus Vaccines market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Prophylactic Hepatitis B Virus Vaccines. Global Prophylactic Hepatitis B Virus Vaccines industry market professional research 2014-2024, is a report which provides the detai......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs